DBV Technologies SA (NAS:DBVT)
$ 3.9 0.835 (27.24%) Market Cap: 68.07 Mil Enterprise Value: 29.75 Mil PE Ratio: 0 PB Ratio: 1.32 GF Score: 39/100

DBV Technologies SA at Barclays Global Healthcare Conference Transcript

Mar 13, 2019 / 02:45PM GMT
Release Date Price: $86.3 (+1.29%)
Geoffrey Christopher Meacham
Barclays Bank PLC, Research Division - MD & Senior Research Analyst

(technical difficulty) I'm the senior biopharma analyst here at the firm. I have Scott Puckhaber from my team on stage with me as well. So we're excited to have DBV Technologies here on stage for a fireside chat. Its Chief Commercial Officer, Kevin Trapp; and Chief Business Officer Susanna Mesa.

Susanna Mesa
DBV Technologies S.A. - Chief Business Officer

Thank you.

Kevin Trapp
DBV Technologies S.A. - Chief Commercial Officer

Hey Geoff, Thanks for having us.

Geoffrey Christopher Meacham;Kevin Trapp
Barclays Bank PLC, Research Division - MD & Senior Research Analyst;DBV Technologies

Welcome guys. Yes, of course. So we've got a lot of questions here, but maybe just if you want to kick it off for maybe some of the audience that aren't as familiar just a kind of a 2 minute, kind of, background, and then we will get right in the question.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot